On the basis of the observations that patients with SLE are often characterized by anti-KIR autoantibodies that could be involved in the decreased NK cell cytotoxicity constituting a risk factor for the development of lupus nephritis, it is possible that the use of anti-KIR autoantibodies could be of clinical relevance. The gene discussed is KIR3DL1; the disease is lupus nephritis.